Personalized Genetic History and Triple Negative Breast Cancer
In summary, this study will be the first to evaluate mDNA in a cohort of self-reported ethnically diverse women in the United States who have been diagnosed with TNBC. The purpose of this study is to identify a mDNA pattern that predisposes women to TNBC.
Once results from all patients are available, statistical analysis will be performed to identify common haplogroups across the ethnicities
Criteria for Inclusion of Subjects:
1. All female patients 18 or older with a diagnosis of TNBC are eligible.
2. Patients are eligible to participate at any time during or after their treatment for TNBC.
3. Vulnerable populations are not included in this trial.